Ligand validation:3OIV

DTT: 2,3-DIHYDROXY-1,4-DITHIOBUTANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3OIV_DTT_A_172	22%	73%	0.311	0.932	0.52	0.54	-	-	1	0	100%	1
3OIV_DTT_A_171	2%	59%	0.401	0.69	0.5	1.05	-	-	2	0	100%	1
4DLY_DTT_A_204	24%	3%	0.271	0.904	2.02	3.81	4	4	3	1	100%	1
4DLV_DTT_A_205	7%	34%	0.306	0.76	1.8	0.83	4	-	1	0	100%	1
4PS1_DTT_C_501	98%	49%	0.059	0.983	1.09	0.9	-	-	0	0	100%	1
1FVG_DTT_A_300	90%	51%	0.082	0.964	0.76	1.12	-	-	0	0	100%	1
5SY6_DTT_A_201	90%	23%	0.082	0.963	0.86	2.28	-	1	0	0	100%	0.75
5ZCM_DTT_A_401	88%	72%	0.101	0.978	0.74	0.35	-	-	0	0	100%	1
3FLK_DTT_D_408	82%	72%	0.095	0.951	0.55	0.54	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.